Clinical Trials
TASMIN4H
Acronym: Telemonitoring And/or Self-Monitoring IN Hypertension
Purpose: Assessment of the efficacy of self-monitored blood pressure with or without telemonitoring for antihypertensive treatment
Format: Randomized, parallel, open-label trial
Treatment Group: Self-monitoring blood pressure with telemonitoring, self-monitoring blood pressure without telemonitoring or usual care (clinic blood pressure)
Number of Participants: 1,182
Centers: 142
Inclusion Criteria: Patients with hypertension aged older than 35 years with blood pressure > 140/90
Primary Outcome(s): Systolic blood pressure at 12 months measured in the clinic
Follow-up: 12 months
Summary: At 12 months, systolic blood pressure was lower in the self-monitoring group (137 mm Hg; standard deviation, 16.7) and the telemonitoring group (136 mm Hg; standard deviation, 16.1) than in the usual-care group (140.4 mm Hg; standard deviation, 16.5). The adjusted mean difference between the self-monitoring group and the usual-care group was -3.5 mm Hg (95% CI, -5.8 to -1.2) and the adjusted mean difference between the telemonitoring group and the usual-care group was -4.7 mm Hg (95% CI, -7 to -2.4).
Original Publication:
McManus RJ, et al. Lancet. 2018; doi:10.1016/S0140-6736(18)30309-X.
Link to Cardiology Today Article: